1.24
price up icon5.98%   0.07
after-market 시간 외 거래: 1.25 0.01 +0.81%
loading
전일 마감가:
$1.17
열려 있는:
$1.18
하루 거래량:
1.36M
Relative Volume:
1.15
시가총액:
$57.19M
수익:
-
순이익/손실:
$-67.68M
주가수익비율:
-0.747
EPS:
-1.66
순현금흐름:
$-54.24M
1주 성능:
-21.02%
1개월 성능:
-31.30%
6개월 성능:
-73.10%
1년 성능:
-92.48%
1일 변동 폭
Value
$1.16
$1.27
1주일 범위
Value
$1.155
$1.68
52주 변동 폭
Value
$1.155
$19.04

Cabaletta Bio Inc Stock (CABA) Company Profile

Name
명칭
Cabaletta Bio Inc
Name
전화
(267) 759-3100
Name
주소
2929 ARCH STREET, PHILADELPHIA, PA
Name
직원
154
Name
트위터
@CabalettaBio
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
CABA's Discussions on Twitter

CABA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CABA
Cabaletta Bio Inc
1.24 57.19M 0 -67.68M -54.24M -1.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-20 다운그레이드 Evercore ISI Outperform → In-line
2024-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-10-10 개시 UBS Buy
2024-02-05 개시 Jefferies Buy
2023-11-29 개시 William Blair Outperform
2023-10-24 개시 Cantor Fitzgerald Overweight
2023-10-19 개시 Stifel Buy
2023-09-05 개시 Citigroup Buy
2023-07-18 개시 Guggenheim Buy
2023-01-27 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-08-30 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-12-08 개시 Wells Fargo Overweight
2021-10-19 재개 Morgan Stanley Overweight
2021-06-30 개시 Mizuho Buy
2021-01-08 개시 Chardan Capital Markets Buy
2020-10-13 개시 H.C. Wainwright Buy
2019-11-19 개시 Cowen Outperform
2019-11-19 개시 Evercore ISI Outperform
2019-11-19 개시 Morgan Stanley Overweight
모두보기

Cabaletta Bio Inc 주식(CABA)의 최신 뉴스

pulisher
11:10 AM

Cabaletta Bio (NASDAQ:CABA) Receives Buy Rating from Guggenheim - MarketBeat

11:10 AM
pulisher
09:10 AM

Cabaletta Bio (NASDAQ:CABA) Price Target Cut to $22.00 by Analysts at Morgan Stanley - MarketBeat

09:10 AM
pulisher
08:55 AM

Cabaletta Bio (NASDAQ:CABA) Posts Earnings Results, Meets Expectations - MarketBeat

08:55 AM
pulisher
08:36 AM

Cabaletta Bio's (CABA) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

08:36 AM
pulisher
08:36 AM

Cabaletta Bio (NASDAQ:CABA) Releases Earnings Results, Meets Estimates - MarketBeat

08:36 AM
pulisher
05:18 AM

Charles Schwab Investment Management Inc. Sells 16,585 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

05:18 AM
pulisher
04:48 AM

Cabaletta Bio Reports Strong Clinical Progress and Q4 2024 Financial Results - MSN

04:48 AM
pulisher
03:41 AM

Cabaletta Bio (NASDAQ:CABA) Price Target Lowered to $7.00 at UBS Group - Defense World

03:41 AM
pulisher
03:01 AM

Cabaletta Bio (NASDAQ:CABA) Given New $3.00 Price Target at Wells Fargo & Company - Defense World

03:01 AM
pulisher
12:00 PM

Cabaletta Bio Advances T Cell Therapies for Autoimmune Diseases - TipRanks

12:00 PM
pulisher
Apr 01, 2025

Cabaletta Bio’s Strategic Advances in Myositis Treatment Drive Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

UBS cuts Cabaletta Bio stock target to $7, maintains Buy rating By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

UBS cuts Cabaletta Bio stock target to $7, maintains Buy rating - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Is Cabaletta Bio Inc (CABA) worth investing in despite its undervalued state? - uspostnews.com

Apr 01, 2025
pulisher
Apr 01, 2025

UBS Adjusts Price Target on Cabaletta Bio to $7 From $10, Keeps Buy Rating - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Cabaletta Bio price target lowered to $22 from $30 at Morgan Stanley - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Stifel cuts Cabaletta Bio stock target to $13, maintains buy By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Mar 31, 2025

Stifel cuts Cabaletta Bio stock target to $13, maintains buy - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

BIT Capital GmbH Invests $431,000 in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio Reports Clinical Wins in Multiple Diseases, Maintains Strong Cash Position - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Sells 16,945 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Cabaletta Bio stock hits 52-week low at $1.59 amid sharp decline By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Cabaletta Bio stock hits 52-week low at $1.59 amid sharp decline - Investing.com Australia

Mar 26, 2025
pulisher
Mar 24, 2025

Are Value Hunters Buying Cabaletta Bio Inc (NASDAQ: CABA) Stock? - Stocks Register

Mar 24, 2025
pulisher
Mar 22, 2025

Head-To-Head Comparison: Cabaletta Bio (NASDAQ:CABA) vs. Outlook Therapeutics (NASDAQ:OTLK) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Cabaletta Bio (CABA) Projected to Post Earnings on Thursday - MarketBeat

Mar 22, 2025
pulisher
Mar 20, 2025

Cellares and Cabaletta Bio Complete Manufacturing Technology Adoption Program - Genetic Engineering and Biotechnology News

Mar 20, 2025
pulisher
Mar 19, 2025

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform - Business Wire

Mar 19, 2025
pulisher
Mar 17, 2025

Cabaletta Bio Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

Cabaletta Bio (CABA) to Release Quarterly Earnings on Thursday - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $22.71 - MarketBeat

Mar 16, 2025
pulisher
Mar 12, 2025

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Target Price at $22.71 - MarketBeat

Mar 12, 2025
pulisher
Mar 09, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 09, 2025
pulisher
Mar 06, 2025

Head-To-Head Contrast: Cabaletta Bio (NASDAQ:CABA) & Cidara Therapeutics (NASDAQ:CDTX) - Defense World

Mar 06, 2025
pulisher
Mar 02, 2025

Cabaletta Bio to Present at TD Cowen 45th Annual Health Care Conference - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

Cabaletta Bio stock hits 52-week low at $1.75 amid sharp decline - Investing.com Australia

Mar 01, 2025
pulisher
Feb 26, 2025

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference - TradingView

Feb 26, 2025

Cabaletta Bio Inc (CABA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):